Key points are not available for this paper at this time.
The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms that mimic peripheral immune tolerance in order to avoid tumoricidal attack. Here, we provide an update of recent accomplishments, unifying concepts, and future challenges to study tumor-associated immune cells, with an emphasis on metastatic carcinomas.
Building similarity graph...
Analyzing shared references across papers
Loading...
Hugo González
Catharina Hagerling
Zena Werb
Genes & Development
UCSF Helen Diller Family Comprehensive Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...
González et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d77093db9d5e1bf4b8a88a — DOI: https://doi.org/10.1101/gad.314617.118